What it is, however, is a remarkably effective body contouring tool that targets stubborn fat deposits that resist even your best diet and exercise efforts
Just as importantly, we now find that APDs act directly on an additional target in the periphery, pancreatic -cells, where D2R/D3R antagonism by these drugs increases glucagon release
Moreover, over 40% of people who start taking GLP-1s quit the medicines within 2 years due to high costs and gastrointestinal side effects such as nausea, diarrhea, vomiting, and constipation, according to a study published in JAMA Network Open last year
(2019) S1472-6483(19)30062-8
And patients of varying races are having different experiences in getting prescribed these drugs